Objectives This study aims to investigate the molecular mechanisms underlying the therapeutic effects of fire needling acupuncture (FNA) in alleviating knee osteoarthritis (KOA) symptoms, focusing on the SDF-1/CXCR4 signaling pathway and macrophage polarization. Methods A KOA mouse model was established using anterior cruciate ligament transection and destabilization of the medial meniscus (ACLT + DMM) surgery. After four weeks, FNA was administered twice weekly for another four weeks. Pain behavior was assessed via weight-bearing and mechanical withdrawal thresholds. Micro-CT, histological staining, immunohistochemistry, and immunofluorescence were utilized to evaluate cartilage and subchondral bone changes, along with relevant markers. Synovial inflammation and macrophage polarization were analyzed, specifically targeting the SDF-1/CXCR4 pathway. The effects of CXCR4 modulation were assessed using AMD3100 (antagonist) and ATI-2341 (agonist). Results FNA treatment improved joint function, reduced pain, alleviated synovial inflammation, and mitigated subchondral bone changes. It decreased cartilage damage while upregulating COL2 and SOX9, and downregulating MMP13. The SDF-1/CXCR4 pathway was activated, leading to a shift in macrophage polarization characterized by reduced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and increased anti-inflammatory cytokine IL-10. M0 macrophage marker F4/80 and M1 marker CD86 were downregulated, whereas M2 marker CD206 was upregulated. The ATI-2341 group exhibited therapeutic effects similar to FNA, while the AMD3100 and AMD3100 + FNA groups showed reduced efficacy. Conclusions FNA alleviates KOA by activating the SDF-1/CXCR4 pathway, modulating macrophage polarization, and reducing cartilage damage and inflammation. These findings highlight the therapeutic potential of FNA in the management of KOA. <Table Float="No" ID="Taba"> <tgroup cols="2"> <colspec align="left" colname="c1" colnum="1" /> <colspec align="left" colname="c2" colnum="2" /> <tbody> <row> <entry align="left" nameend="c2" namest="c1"> Key Points • Fire needling acupuncture (FNA) differentially regulates SDF-1/CXCR4 signaling in knee osteoarthritis (KOA), where synovial/cartilaginous upregulation enhances mesenchymal stem cell (MSC) homing to potentiate tissue repair, while subchondral suppression mitigates pathological bone remodeling. • FNA activates the JAK1/STAT6/PPAR-γ axis to drive macrophage phenotypic switching from pro-inflammatory M1 to anti-inflammatory M2 states, thereby preserving cartilage matrix integrity through reduced collagenase activity. • Combinatorial CXCR4 inhibition/agonist studies demonstrate FNA’s targetable effects across tissue compartments, providing a mechanistic framework to refine acupuncture-based regenerative strategies. • This work establishes a precision medicine framework for degenerative joint diseases by bridging traditional acupuncture with immunomodulatory biologics to target immune-microenvironment crosstalk. </entry> </row> </tbody> </tgroup> </Table>

Fire needling acupuncture attenuates synovial inflammation and cartilage degeneration in knee osteoarthritis via SDF-1/CXCR4-mediated macrophage polarization

期刊论文
发表日期：

2025年8月8日

查看全文

Jiangyan Wei,
Xin Yang,
Luopeng Zhao,
Xueyan Liu,
Xiaobo Ge,
Jiarun Zhang,
Jun Zhou,
Chengcheng Zhang,
Yine Song,
Wenshan Li,
Fang Yuan,
Yizhan Wang,
Lu Liu,
Bin Li

摘要

Objectives

This study aims to investigate the molecular mechanisms underlying the therapeutic effects of fire needling acupuncture (FNA) in alleviating knee osteoarthritis (KOA) symptoms, focusing on the SDF-1/CXCR4 signaling pathway and macrophage polarization.

Methods

A KOA mouse model was established using anterior cruciate ligament transection and destabilization of the medial meniscus (ACLT + DMM) surgery. After four weeks, FNA was administered twice weekly for another four weeks. Pain behavior was assessed via weight-bearing and mechanical withdrawal thresholds. Micro-CT, histological staining, immunohistochemistry, and immunofluorescence were utilized to evaluate cartilage and subchondral bone changes, along with relevant markers. Synovial inflammation and macrophage polarization were analyzed, specifically targeting the SDF-1/CXCR4 pathway. The effects of CXCR4 modulation were assessed using AMD3100 (antagonist) and ATI-2341 (agonist).

Results

FNA treatment improved joint function, reduced pain, alleviated synovial inflammation, and mitigated subchondral bone changes. It decreased cartilage damage while upregulating COL2 and SOX9, and downregulating MMP13. The SDF-1/CXCR4 pathway was activated, leading to a shift in macrophage polarization characterized by reduced pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and increased anti-inflammatory cytokine IL-10. M0 macrophage marker F4/80 and M1 marker CD86 were downregulated, whereas M2 marker CD206 was upregulated. The ATI-2341 group exhibited therapeutic effects similar to FNA, while the AMD3100 and AMD3100 + FNA groups showed reduced efficacy.

Conclusions

FNA alleviates KOA by activating the SDF-1/CXCR4 pathway, modulating macrophage polarization, and reducing cartilage damage and inflammation. These findings highlight the therapeutic potential of FNA in the management of KOA.

Key Points

• Fire needling acupuncture (FNA) differentially regulates SDF-1/CXCR4 signaling in knee osteoarthritis (KOA), where synovial/cartilaginous upregulation enhances mesenchymal stem cell (MSC) homing to potentiate tissue repair, while subchondral suppression mitigates pathological bone remodeling.

• FNA activates the JAK1/STAT6/PPAR-γ axis to drive macrophage phenotypic switching from pro-inflammatory M1 to anti-inflammatory M2 states, thereby preserving cartilage matrix integrity through reduced collagenase activity.

• Combinatorial CXCR4 inhibition/agonist studies demonstrate FNA’s targetable effects across tissue compartments, providing a mechanistic framework to refine acupuncture-based regenerative strategies.

• This work establishes a precision medicine framework for degenerative joint diseases by bridging traditional acupuncture with immunomodulatory biologics to target immune-microenvironment crosstalk.